Evidence map›Paper›PMID 28152442›Full record

ReviewCurrent opinion in chemical biology2017

Synthetic metabolism: metabolic engineering meets enzyme design.

Tobias J Erb, Patrik R Jones, Arren Bar-Even

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed.

  1. Natural and Synthetic Metabolic Architectures.Chembiochem : a European journal of chemical biology · 2026
    Article
  2. Review
  3. Metabolic engineering ofBiodesign research · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. New-to-nature CONature communications · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Photosynthesis 2.0: Realizing New-to-Nature COCold Spring Harbor perspectives in biology · 2024
    Review
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tobias J ErbBiochemistry and Synthetic Biology of Microbial Metabolism Group, Max Planck Institute for Terrestrial Microbiology & LOEWE Research Center for Synthetic Microbiology (SYNMIKRO), Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany. Electronic address: toerb@mpi-marburg.mpg.de.
Patrik R JonesDepartment of Life Sciences, Imperial College London, Sir Alexander Fleming Building, London SW7 2AZ, UK. Electronic address: p.jones@imperial.ac.uk.
Arren Bar-EvenSystems and Synthetic Metabolism Group, Max Planck Institute for Molecular Plant Physiology, Potsdam-Golm, Am Mühlenberg 1, D-14476 Potsdam, Germany.

Funding

European Research Council 637675
6 · The paper itself

Abstract

Metabolic engineering aims at modifying the endogenous metabolic network of an organism to harness it for a useful biotechnological task, for example, production of a value-added compound. Several levels of metabolic engineering can be defined and are the topic of this review. Basic 'copy, paste and fine-tuning' approaches are limited to the structure of naturally existing pathways. 'Mix and match' approaches freely recombine the repertoire of existing enzymes to create synthetic metabolic networks that are able to outcompete naturally evolved pathways or redirect flux toward non-natural products. The space of possible metabolic solution can be further increased through approaches including 'new enzyme reactions', which are engineered on the basis of known enzyme mechanisms. Finally, by considering completely 'novel enzyme chemistries' with de novo enzyme design, the limits of nature can be breached to derive the most advanced form of synthetic pathways. We discuss the challenges and promises associated with these different metabolic engineering approaches and illuminate how enzyme engineering is expected to take a prime role in synthetic metabolic engineering for biotechnology, chemical industry and agriculture of the future.

Indexed as

EnzymesMetabolic EngineeringProtein EngineeringEnzymes

Identifiers

PMID28152442
PMCPMC7610756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.